Severity of COVID-19 in pregnancy : A review of current evidence
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd..
Coronavirus disease 19 (COVID-19) has recently emerged as a major threat to human health. Infections range from asymptomatic to severe (increased respiratory rate, hypoxia, significant lung involvement on imaging) or critical (multi-organ failure or dysfunction or respiratory failure requiring mechanical ventilation or high-flow nasal cannula). Current evidence suggests that pregnancy women are at increased risk of severe disease, specifically the need for hospitalization, ICU admission, and mechanical ventilation, and the already complex management of infection with an emerging pathogen may be further complicated by pregnancy. The goal of this review is to provide an overview of what is known about the clinical course of COVID-19 in pregnancy, drawing on (a) experience with other coronaviruses such as SARS and MERS, (b) knowledge of immunologic and physiologic changes in pregnancy and how these might impact infection with SARS-CoV-2, and (c) the current literature reporting outcomes in pregnant women with SARS-CoV-2. We also briefly summarize considerations in management of severe COVID-19 in pregnancy.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:84 |
|---|---|
| Enthalten in: |
American journal of reproductive immunology (New York, N.Y. : 1989) - 84(2020), 5 vom: 15. Nov., Seite e13332 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kucirka, Lauren M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 28.12.2020 Date Revised 28.12.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/aji.13332 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM314384340 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM314384340 | ||
| 003 | DE-627 | ||
| 005 | 20231225152618.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/aji.13332 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1047.xml |
| 035 | |a (DE-627)NLM314384340 | ||
| 035 | |a (NLM)32865300 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kucirka, Lauren M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Severity of COVID-19 in pregnancy |b A review of current evidence |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.12.2020 | ||
| 500 | |a Date Revised 28.12.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. | ||
| 520 | |a Coronavirus disease 19 (COVID-19) has recently emerged as a major threat to human health. Infections range from asymptomatic to severe (increased respiratory rate, hypoxia, significant lung involvement on imaging) or critical (multi-organ failure or dysfunction or respiratory failure requiring mechanical ventilation or high-flow nasal cannula). Current evidence suggests that pregnancy women are at increased risk of severe disease, specifically the need for hospitalization, ICU admission, and mechanical ventilation, and the already complex management of infection with an emerging pathogen may be further complicated by pregnancy. The goal of this review is to provide an overview of what is known about the clinical course of COVID-19 in pregnancy, drawing on (a) experience with other coronaviruses such as SARS and MERS, (b) knowledge of immunologic and physiologic changes in pregnancy and how these might impact infection with SARS-CoV-2, and (c) the current literature reporting outcomes in pregnant women with SARS-CoV-2. We also briefly summarize considerations in management of severe COVID-19 in pregnancy | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a clinical course | |
| 650 | 4 | |a epidemiology | |
| 650 | 4 | |a outcomes | |
| 650 | 4 | |a pregnancy | |
| 700 | 1 | |a Norton, Alexandra |e verfasserin |4 aut | |
| 700 | 1 | |a Sheffield, Jeanne S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of reproductive immunology (New York, N.Y. : 1989) |d 1990 |g 84(2020), 5 vom: 15. Nov., Seite e13332 |w (DE-627)NLM012641731 |x 1600-0897 |7 nnns |
| 773 | 1 | 8 | |g volume:84 |g year:2020 |g number:5 |g day:15 |g month:11 |g pages:e13332 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/aji.13332 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 84 |j 2020 |e 5 |b 15 |c 11 |h e13332 | ||